| 摘要 |
The present invention is in the field of neurological disorders. It relates to the use of ribavirin (1-D-D-ribofuranosyl-1H- 1,2, 4-triazole-3-carboxamide) in combination with an interferon (IFN) for the manufacture of a medicament for treatment and/or prevention of a demyelinating disease. In particular, it relates to the use of a combination of Ribavirin and IFN-beta for treatment and/or prevention of a demyelinating disease, such as multiple sclerosis. |
